Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-13,900
Closed -$236K 415
2016
Q1
$236K Sell
13,900
-1,176
-8% -$19.6K 0.03% 346
2015
Q4
$309K Buy
15,076
+440
+3% +$9.15K 0.04% 296
2015
Q3
$314K Buy
+14,636
New +$327K 0.05% 301

Other funds holding DXCM

Gerstein Fisher's DXCM Position: Q2 2016 in Review

Gerstein Fisher sold out of DexCom (DXCM) in Q2 2016, closing a stake of 13,900 shares — an estimated $236K sold.

Gerstein Fisher first reported a position in DXCM in Q3 2015 and held it in 3 quarters. The position peaked at $314K in Q3 2015. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2016.

  • Gerstein Fisher reported no remaining DexCom position as of Q2 2016 after selling out during the quarter.
  • Gerstein Fisher sold 13,900 DexCom shares in Q2 2016, an estimated $236K.
  • Gerstein Fisher first reported a position in DexCom in Q3 2015 and held it in 3 quarters.
  • Gerstein Fisher's DexCom position peaked at $314K in Q3 2015.
  • 279 funds tracked by Wall St. Rank held DexCom as of Q2 2016.

Based on Gerstein Fisher's 13F filing for Q2 2016, filed 8 Aug 2016.